How Apeiron’s $3.89 Private Placement Fuels Growth & Dilution in Enhanced Group
A deep dive into Apeiron Investment Group’s 2026 private placement in Enhanced Group reveals bullish intent, strategic warrants, and potential dilution – a must‑read for investors tracking sports‑medicine growth.
3 minutes to read









